Family history and symptom levels during treatment for bipolar I affective disorder

Biological Psychiatry

Volumn 47, Issue 12, 2000, Pages 1034-1042

  Coryell, William ^a   Akiskal, Hagop ^b   Leon, Andrew C ^c   Turvey, Carolyn ^a   Solomon, David ^d   Endicott, Jean ^e  

^a UNIVERSITY OF IOWA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Anticonvulsant response; Bipolar disorder; Family history; Follow up; Lithium response; Prognosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

ADULT; ARTICLE; DRUG RESPONSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RELATIVE; RISK ASSESSMENT; SCHIZOIDISM; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; FAMILY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0034116508     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00242-0     Document Type: Article

References (30)

1. Abou-Saleh M.T., Coppen A.J. Who responds to prophylactic lithium? J Affect Disord. 10:1986;115-125.
2. Abou-Saleh M.T., Coppen A.J. Predictors of long-term outcome of mood disorder on prophylactic lithium. Lithium. 1:1990;27-35.
3. Andreasen N.C., Endicott J., Spitzer R.L., Winokur G. The Family History method using diagnostic criteria. Arch Gen Psychiatry. 34:1977;1229-1235.
4. Andreasen N.C., Rice J., Endicott J., Coryell W., Grove W.M., Reich T. Familial rates of affective disorders. Arch Gen Psychiatry. 44:1987;461-469.
5. Andreasen N.C., Rice J., Endicott J., Reich T., Corryell W. The family history approach to diagnosis. Arch Gen Psychiatry. 43:1986;421-429.
6. Coryell W., Endicott J., Winokur G., Akiskal H., Solomon D., Leon A., et al. Characteristics and significance of untreated major depressive disorder. Am J Psychiatry. 152:1995;1124-1129.
7. 3 prophylaxis failure. Br J Psychiatry. 129:1976;40-44.
8. Endicott J., Spitzer A.L. A diagnostic interview The Schedule for Affective Disorders and Schizophrenia . Arch Gen Psychiatry. 35:1978;837-844.
9. Engstrom C., Astrom M., Nordqvist-Karlsson B., Adolfsson R., Nylader P.O. Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Biol Psychiatry. 42:1997;425-433.
10. Grof P., Alda M., Grof E., Zvolsky P., Walsh M. Lithium response and genetics of affective disorders. J Affect Disord. 32:1994;85-95.
11. Kalbfleisch J.D., Prentice R.L. The Statistical Analysis of Failure Time Data. 1980;Wiley and Sons, New York.
12. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
13. Keller M.B., Lavori P.W., Friedman B., Neilsen E., Endicott J., McDonald-Scott P., et al. The Longitudinal Interval Follow-Up Evaluation. Arch Gen Psychiatry. 44:1987;540-548.
14. Leonhard K., Korff I., Shulz M. Die temperamente in den familien der monopolaren and bipolaren phasischen psychosen. Psychiat Nevrol. 143:1962;416.
15. Maj M., Arena F., Lovero N., Piorzzi R., Kemali D. Factors associated with response to lithium prophylaxis in DSM-III major depression and bipolar disorder. Pharmacopsychiatry. 18:1985;309-313.
16. Mendlewicz J., Fieve R.R., Stallone F. Relationship between the effectiveness of Li Rx and family history. Am J Psychiatry. 130:1973;1011-1013.
17. Mendlewicz J., Verbanck P., Linkowski P., Wilmotte J. Lithium accumulation in erythrocytes of manic depressive patients; in vitro twin study. Br J Psychiatry. 133:1978;436-444.
18. Nylander P.O., Engstrom C., Chotai J., Wahlstrom J., Adolfsson R. Anticipation in Swedish families with bipolar effective disorder. J Med Genet. 31:1994;686-689.
19. Nylander P.O., Engstrom C., Karlsson B.N., Astrom M. Family history of affective disorders and the significance of prophylactic effect of lithium treatment. Biol Psychiatry. 45:1999;1078-1081.
20. Perris C. A study of bipolar (manic depressive) and unipolar recurrent depressive psychoses. I. Genetic investigation. Acta Psychiatr Scand Suppl. 194:1966;15-44.
21. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Correlates of antimanic response to carbamazepine. Psychiatry Res. 21:1987;71-83.
22. Rice J., Reich T., Andreasen N.C., Endicott J., VanEerdewegh N., Fishman R. The familial transmission of bipolar illness. Arch Gen Psychiatry. 44:1987;441-447.
23. Rice J.P., Rochberg N., Endicott J., Lavori P.W., Miller C. Stability of psychiatric diagnoses. Arch Gen Psychiatry. 49:1992;824-830.
24. Schexnayder L.W., Hirschowitz J., Sautter F.J., Garver D.L. Predictors of response of lithium in patients with psychoses. Am J Psychiatry. 152:1995;1511-1513.
25. Shapiro D., Quitkin F., Fleiss J. Response to maintenance therapy in bipolar illness. Arch Gen Psychiatry. 46:1989;401-405.
26. Smeraldi E., Petroccione A., Gasperini M., Macciardi F., Orsini A., Kidd K.K., et al. Outcomes on lithium treatment as a tool for genetic studies of affective disorders. J Affect Disord. 6:1984;139-151.
27. Spitzer R.L., Endicott J., Robins E. Research Diagnostic Criteria Rationale and reliability . Arch Gen Psychiatry. 35:1978;773-782.
28. Taylor M.A., Abrams R. Prediction of treatment response in mania. Arch Gen Psychiatry. 38:1981;800-803.
29. Weissman M.M., Merikangas K.R., Wickramaratne P., Kidd K.K., Prusoff B.A., Leckman J.F., et al. Understanding the clinical heterogeneity of major depression using family data. Arch Gen Psychiatry. 43:1986;430-434.
30. Zvolsky P., Vinarova E., Dostal T., Soucek K. Family history of manic depressive and endogenous depressive patients and clinical affective treatment with lithium. Act Nerv Super (Praha). 16:1974;194-195.